1.
Schlenk RF, Montesinos P, Kim H-J, Romero-Aguilar A, Vrhovac R, Patkowska E, Žak P, Wang P-N, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP. Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial. haematol [Internet]. 2025Sep.1 [cited 2025Dec.6];110(9):2024-39. Available from: https://haematologica.org/article/view/11974